tert-butyl 1,7-diazaspiro[4.4]nonane-1-carboxylate
|
|
885268-47-3
|
4-(Boc-Amino)-2-methylphenylboronic acid pinacol ester
|
|
1256360-04-9
|
4-{1H-Pyrrolo[3,2-b]pyridin-3-yl}piperidine
|
|
149669-49-8
|
3-(tert-butyl)-4-(naphthylmethylene)-1-phenyl-2-pyrazolin-5-one
|
|
1024754-31-1
|
3-Amino-1-[(4-fluorophenyl)methyl]thiourea
|
|
871548-21-9
|
2-(2-Bromophenyl)ethanol
|
|
1074-16-4
|
2-Amino-3-chloro-6-fluorobenzoic acid
|
|
946117-78-8
|
2'-O-Methylisoliquiritigenin
|
|
112408-67-0
|
2-(4-Propoxyphenyl)-1,3-thiazole-4-carboxylic acid
|
|
938145-71-2
|
5-(Methoxycarbonyl)-2-methylthiophene-3-carboxylic acid
|
|
2193061-63-9
|
3-Benzoyloxolane
|
|
1248356-66-2
|
H-TMLLQPAGSLGSYSYR^-OH
|
|
|
6-Bromo-1-ethyl-1H-1,3-benzodiazol-2-amine
|
|
24810-29-5
|
NudC antibody (Ser326)
|
|
|
2-chloro-5-iodo-3-(trifluoromethyl)pyridine
|
|
887707-25-7
|
PASK antibody
|
|
|
Fmoc-D-glu-OtBu
|
|
109745-15-5
|
2-(4-Fluorophenyl)-N-hydroxyacetamide
|
|
2593-88-6
|
H-IIAPPERK-OH
|
|
|
4-Bromophenetole
|
|
588-96-5
|
PAR-2 (6-1) amide (mouse, rat) trifluoroacetate salt
|
|
245329-01-5
|
Acetyl coenzyme A trilithium salt trihydrate
|
|
496948-93-7
|
2-Amino-N-(2,4-dimethoxyphenyl)benzamide
|
|
93988-27-3
|
1,3-Dimethyl-1H-indol-6-ol
|
|
1550823-22-7
|
2-(Hydrazinylmethyl)-6-methylpyridine dihydrochloride
|
|
1989672-56-1
|
Methyl 1-methanesulfonylpyrrolidine-2-carboxylate
|
|
1487500-62-8
|
Sunitinib base - Bio-X ?
|
|
557795-19-4
|
6-(4-Chlorophenyl)-3-methyl-[1,2]oxazolo[5,4-b]pyridine-4-carboxylic acid
|
|
753468-45-0
|
1-(2-Phenylethyl)cyclopropan-1-amine hydrochloride
|
|
2060063-29-6
|
Methyl 2-amino-2-[3-(pyridin-4-yl)phenyl]acetate dihydrochloride
|
|
2305253-49-8
|
Methyl 2-amino-4-oxo-1H,4H-thieno[3,2-d]pyrimidine-7-carboxylate
|
|
2031261-05-7
|
Mitazalimab
|
|
2055640-86-1
|
RMND1 antibody
|
|
|
Maltoeicosaose
|
|
|
4-(Dimethylamino)nicotinic acid
|
|
83039-02-5
|
(S,S,S)-Enalapril maleate
|
|
76095-16-4
|
N-(6-Hydroxyhexyl)trifluoroacetamide
|
|
40248-34-8
|
2-(dimethylphosphoryl)aniline
|
|
1197953-47-1
|
4-Chloro-2-(1H-1,2,3-triazol-4-yl)phenol
|
|
1378976-02-3
|
HCV NS4A Protein (22-33) (FDA strain)
|
|
317335-37-8
|
1-[2-(3-Chloro-2-hydroxypropoxy)phenyl]-3-phenyl-1-propanone
|
|
165279-79-8
|
Fluorescein disodium salt
|
|
518-47-8
|
Pheophytin B
|
|
3147-18-0
|
6-Anilinoquinoline-5,8-quinone
|
|
91300-60-6
|
MVD Blocking Peptide
|
|
|
2-(3,5-Dichlorophenyl)-2-methylpropanoic acid
|
|
825643-82-1
|
2-(4-methyl-2-phenyl-1,3-thiazol-5-yl)acetate lithium
|
|
2241141-43-3
|
Gliclazide
|
|
21187-98-4
|
(3-Chloropyridin-4-yl)methanesulfonamide
|
|
1492527-58-8
|
Diphenyl(2,4,6-triMethylbenzoyl)phosphine oxide
|
|
75980-60-8
|
1',2'-Dehydro dicyclomine
|
|
109158-77-2
|
2-[(1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}piperidin-3-yl)methoxy]acetic acid
|
|
2137856-10-9
|
3,3-Dimethylglutaric Anhydride
|
|
4160-82-1
|
8-[(3-Amino-4-methylbenzoyl)amino]-1,3,5-naphthalenetrisulfonic acid trisodium
|
|
69031-55-6
|
3-((phenylcyclopentyl)carbonylamino)benzoic acid
|
|
885561-53-5
|
2-(7-Methoxy-1-benzofuran-3-yl)acetic acid
|
|
79477-01-3
|
1-[3-(Chloromethyl)-5-fluoro-2-hydroxyphenyl]ethan-1-one
|
|
565192-25-8
|
6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid
|
|
99199-60-7
|
3-phenyl-2-(2-thienylcarbonyl)indeno[3,2-c]pyrazol-4-one
|
|
1020251-78-8
|
ACP1 Blocking Peptide
|
|
|
KRT36 Blocking Peptide
|
|
|
5-Decyano 5-carboxymilrinone
|
|
80047-38-7
|
2-[3-(Trifluoromethyl)-1H-pyrazol-5-yl]acetic acid
|
|
1374032-37-7
|
H-TYLPAVDEK-OH
|
|
|
H-YMLDLQPETV-OH
|
|
|
Triciribine
|
|
35943-35-2
|
N-(butan-2-yl)-4-(2-fluorophenyl)piperazine-1-carboxamide
|
|
1023527-01-6
|
1-Linoleoyl-rac-glycerol
|
|
2277-28-3
|
TOB1 Blocking Peptide
|
|
|
1-(2-Chloroethyl)-3-methylpiperidine hydrochloride
|
|
85068-70-8
|
H-TTHYGSLPQK-OH
|
|
|
AurA antibody
|
|
|
rac-Methyl (1R,5R,6R)-6-aminobicyclo[3.2.0]heptane-3-carboxylate hydrochloride
|
|
2155848-04-5
|
N-(3-Aminopropyl)-N-cyclopropylcyclobutanecarboxamide hydrochloride
|
|
1269152-74-0
|
(2S,3S,4R,5R)-3,4-O-Benzylidene-2-cyano-N-(4-methoxybenzyl)-3,4,5-trihydroxy-piperidine
|
|
|
2-[(2-Fluorophenyl)sulfanyl]acetohydrazide
|
|
848052-92-6
|
4-Bromo-7-nitro-2,3-dihydro-isoindol-1-one
|
|
765948-99-0
|
2-({[(3-Bromophenyl)carbamoyl]methyl}sulfanyl)propanoic acid
|
|
1016786-75-6
|
FAM107A Blocking Peptide
|
|
|
3-(4-Hydroxyphenyl)propionitrile
|
|
17362-17-3
|
4-Methanesulfonyl-2-methylbutan-2-amine
|
|
1250515-16-2
|
6-Chloro-5-iodo-3-nitropyridin-2-amine
|
|
790692-90-9
|
2-Chloro-5-(difluoromethyl)aniline hydrochloride
|
|
1803567-53-4
|
RPA2 antibody
|
|
|
[3-(tert-Butoxy)cyclobutyl]methanamine hydrochloride
|
|
2241129-69-9
|
PUMA BH3
|
|
|
N,N-Diethyl-p-phenylenediamine oxalate
|
|
62637-92-7
|
Ethyl 5-bromo-2-methylnicotinate
|
|
129477-21-0
|
2-[(2S)-5,5-Dimethylmorpholin-2-yl]acetic acid
|
|
160415-07-6
|
2-Chloro-afatinib
|
|
2223677-63-0
|
GPR107 antibody
|
|
|
Erythromycin EP impurity L
|
|
127955-44-6
|
3-(Methanesulfonylmethyl)pyrrolidine hydrochloride
|
|
1803584-69-1
|
alpha,alpha,2,4-Tetrachlorotoluene
|
|
134-25-8
|
2-amino-5-bromo-3-pyridinecarbaldehyde
|
|
206997-15-1
|
Methyl 6-amino-6-deoxy-a-D-glucopyranoside
|
|
5155-47-5
|
H-FQDGDLTLYQSNTILR^-OH
|
|
|
4,5-Dibromo-N-(2,2-diethoxyethyl)-1H-pyrrole-2-carboxamide
|
|
1461713-43-8
|
3-Chloro-5-methoxyisoquinoline
|
|
1691715-12-4
|
[4-Fluoro-1-[(1-methyl-1H-pyrazol-4-yl)methyl]pyrrolidin-2-yl]methanamine
|
|
1820575-42-5
|